WallStreetZenWallStreetZen

NASDAQ: STIM
Neuronetics Inc Stock Forecast, Predictions & Price Target

Open Broker Account

Analyst price target for STIM

Based on 1 analyst offering 12 month price targets for Neuronetics Inc.
Min Forecast
$12.00+410.64%
Avg Forecast
$12.00+410.64%
Max Forecast
$12.00+410.64%

Should I buy or sell STIM stock?

Based on 2 analysts offering ratings for Neuronetics Inc.
Buy
Strong Buy
0 analysts 0%
Buy
1 analysts 50%
Hold
1 analysts 50%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their STIM stock forecasts and price targets.

STIM stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
JMP Securities
Bottom 12%
12
BuyMaintains$12.00+410.64%2021-10-14
BTIG
Top 8%
93
HoldDowngradesN/AN/A2021-10-13

1 of 1

Forecast return on equity

Is STIM forecast to generate an efficient return?
Company
-33.97%
Industry
536.32%
Market
108.79%
STIM's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is STIM forecast to generate an efficient return on assets?
Company
-18.9%
Industry
11.48%
STIM is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

STIM earnings per share forecast

What is STIM's earnings per share in the next 3 years based on estimates from 2 analysts?
Avg 1 year Forecast
-$1.65
Avg 2 year Forecast
-$1.49
Avg 3 year Forecast
-$0.86

STIM revenue forecast

What is STIM's revenue in the next 3 years based on estimates from 2 analysts?
Avg 1 year Forecast
$61.2M+3.21%
Avg 2 year Forecast
$70.9M+19.52%
Avg 3 year Forecast
$84.1M+41.68%
STIM's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

STIM revenue growth forecast

How is STIM forecast to perform vs Diagnostics & Research companies and vs the US market?
Company
10.09%
Industry
3.74%
Market
8.22%
STIM's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
STIM's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

STIM vs Diagnostic & Research Stocks

TickerPricePrice TargetUp/downsideConsensus
STIM$2.35$12.00+410.64%Buy
BWAY$3.53$13.00+268.27%Strong Buy
XGN$3.43$17.00+395.19%Strong Buy
SERA$1.69$11.75+595.27%Buy
BDSX$1.28$11.00+759.38%Buy

Neuronetics Stock Forecast FAQ

Is Neuronetics Stock a good buy in 2022, according to Wall Street analysts?

The consensus among 2 Wall Street analysts covering (NASDAQ: STIM) stock is to Buy STIM stock.

Out of 2 analysts, 0 (0%) are recommending STIM as a Strong Buy, 1 (50%) are recommending STIM as a Buy, 1 (50%) are recommending STIM as a Hold, 0 (0%) are recommending STIM as a Sell, and 0 (0%) are recommending STIM as a Strong Sell.

If you're new to stock investing, here's how to buy Neuronetics stock.

What is STIM's earnings growth forecast for 2022-2024?

(NASDAQ: STIM) Neuronetics's forecast annual earnings growth rate of N/A is not forecast to beat the US Diagnostics & Research industry's average forecast earnings growth rate of 14.78%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 18.27%.

Neuronetics's earnings in 2022 is -$37,047,000.On average, 2 Wall Street analysts forecast STIM's earnings for 2022 to be -$44,587,613, with the lowest STIM earnings forecast at -$44,857,841, and the highest STIM earnings forecast at -$44,587,613. On average, 2 Wall Street analysts forecast STIM's earnings for 2023 to be -$40,263,966, with the lowest STIM earnings forecast at -$44,587,613, and the highest STIM earnings forecast at -$35,670,091.

In 2024, STIM is forecast to generate -$23,239,605 in earnings, with the lowest earnings forecast at -$23,239,605 and the highest earnings forecast at -$23,239,605.

What is STIM's revenue growth forecast for 2022-2024?

(NASDAQ: STIM) Neuronetics's forecast annual revenue growth rate of 10.09% is forecast to beat the US Diagnostics & Research industry's average forecast revenue growth rate of 3.74%, and and it is also forecast to beat the US market's average forecast revenue growth rate of 8.22%.

Neuronetics's revenue in 2022 is $59,331,000.On average, 2 Wall Street analysts forecast STIM's revenue for 2022 to be $1,654,740,913, with the lowest STIM revenue forecast at $1,648,390,556, and the highest STIM revenue forecast at $1,661,091,270. On average, 2 Wall Street analysts forecast STIM's revenue for 2023 to be $1,916,186,464, with the lowest STIM revenue forecast at $1,875,382,042, and the highest STIM revenue forecast at $1,956,990,886.

In 2024, STIM is forecast to generate $2,271,536,232 in revenue, with the lowest revenue forecast at $2,271,536,232 and the highest revenue forecast at $2,271,536,232.

What is STIM's forecast return on assets (ROA) for 2022-2024?

(NASDAQ: STIM) forecast ROA is -18.9%, which is lower than the forecast US Diagnostics & Research industry average of 11.48%.

What is STIM's Price Target?

According to 1 Wall Street analyst that have issued a 1 year STIM price target, the average STIM price target is $12.00, with the highest STIM stock price forecast at $12.00 and the lowest STIM stock price forecast at $12.00.

The Wall Street analyst predicted that Neuronetics's share price could reach $12.00 by Oct 14, 2022. The average Neuronetics stock price prediction forecasts a potential upside of 410.64% from the current STIM share price of $2.35.

What is STIM's Earnings Per Share (EPS) forecast for 2022-2024?

(NASDAQ: STIM) Neuronetics's current Earnings Per Share (EPS) is -$1.39. On average, analysts forecast that STIM's EPS will be -$1.65 for 2022, with the lowest EPS forecast at -$1.66, and the highest EPS forecast at -$1.65. On average, analysts forecast that STIM's EPS will be -$1.49 for 2023, with the lowest EPS forecast at -$1.65, and the highest EPS forecast at -$1.32. In 2024, STIM's EPS is forecast to hit -$0.86 (min: -$0.86, max: -$0.86).

What is STIM's forecast return on equity (ROE) for 2022-2024?

(NASDAQ: STIM) forecast ROE is -33.97%, which is considered weak.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.